IN8bio, Inc. operates as a clinical stage biopharmaceutical company, which focuses on developing novel therapies for the treatment of cancers, including solid tumors, by employing allogeneic, autologous and genetically modified gamma-delta T cells. The company was founded by Lawrence S. Lamb and William T. Ho on February 8, 2016 and is headquartered in New York, NY.
Sector:
Health Technology
Industry:
Biotechnology
Employees:
18
Frequently Asked Questions
What is Market Cap of IN8bio Inc?
Market cap, also known as market capitalization, is the total market value of a company. It’s calculated by multiplying the current market price by the total number of shares outstanding. IN8bio Inc market cap is $9.49M.
What is the 52-week high for IN8bio Inc?
52 week high is the highest price of a stock in the past 52 weeks, or one year. IN8bio Inc 52 week high is $16.70 as of September 13, 2025.
What is the 52-week low for IN8bio Inc?
52 week low is the lowest price of a stock in the past 52 weeks, or one year. IN8bio Inc 52 week low is $1.91 as of September 13, 2025.
What is IN8bio Inc stock price today?
IN8bio Inc stock price today is $2.10.
What was IN8bio Inc stock price yesterday?
IN8bio Inc stock price yesterday was $2.09.
What is the PE ratio of IN8bio Inc?
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It’s calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company’s Market Cap by the Net Profit. IN8bio Inc’s P/E ratio is -0.20.
What is the Price-to-Book ratio of IN8bio Inc?
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It’s calculated by dividing a company’s market capitalization by its book value. IN8bio Inc P/B ratio is 0.5593.
What is the 50-day moving average of IN8bio Inc?
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It’s calculated by averaging the closing stock price over the previous 50 trading days. IN8bio Inc 50-day moving average is $2.23.